Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 4/2019

01-04-2019 | Obesity | Original Contributions

Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases

Authors: Wang Xiaosong, Su Chongyu, Shen Xuqi, Yu Peiwu, Zhao Yongliang

Published in: Obesity Surgery | Issue 4/2019

Login to get access

Abstract

Objectives

To explore the risk factors for relapse of hyperglycemia in obese patients with type II diabetes mellitus (T2DM) who received laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery.

Methods

A retrospective analysis was performed on all obese patients with T2DM who underwent a LRYGB during the period 2011–2013. Demographics, preoperative body mass index (BMI), preoperative glycated hemoglobin A1c (HbA1c), adherence to lifestyle intervention, preoperative medication of insulin, and the time interval between surgery and diagnosis of T2DM were investigated and compared.

Results

A total of 24 patients were included in our study. The median age was 45.5 years, the median BMI was 29.9 kg/m2, and the median HbA1c was 7.9%. Out of 24 patients, 54.2% (13/24) experienced a relapse of hyperglycemia. The 1-year, 3-year, and 5-year relapse rates were 4.2%, 12.5%, and 50.0%, respectively. The preoperative HbA1c level, C-peptide (2 h) level, and C-peptide (3 h) level were identified as independent variables for the relapse of hyperglycemia (8.11 ± 0.48 vs 7.72 ± 0.37 kg/m2, p = 0.036; 4.35 ± 1.46 vs 7.13 ± 4.10 ng/ml, p = 0.032; 3.76 ± 0.61 vs 5.99 ± 3.39 ng/ml, p = 0.029). Lifestyle intervention could reduce the hyperglycemia relapse rate (66.7 vs 41.7%) after LRYGB surgery.

Conclusions

The preoperative HbA1c level and C-peptide level at surgery have an important significance in predicting the relapse of hyperglycemia after LRYGB surgery; lifestyle intervention is crucial for these patients.
Literature
1.
Baena-Díez JM, Peñafiel J, Subirana I, Ramos R, Elosua R, Marín-Ibañez A, Guembe MJ, Rigo F, Tormo-Díaz MJ, Moreno-Iribas C, Cabré JJ, Segura A, García-Lareo M, Gómez de la Cámara A, Lapetra J, Quesada M, Marrugat J, Medrano MJ, Berjón J, Frontera G, Gavrila D, Barricarte A, Basora J, García JM, Pavone NC, Lora-Pablos D, Mayoral E, Franch J, Mata M, Castell C, Frances A, Grau M, FRESCO Investigators. Risk of cause-specific death in individuals with diabetes: a competing risks analysis [J]. Diabetes Care, 2016, 39(11): 1987, 1995.
2.
Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045 [J]. Diabetes Res Clin Pract. 2018;138:271–81.CrossRefPubMed
3.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial [J]. Lancet. 2015;386(9997):964–73.CrossRefPubMed
4.
Aminian A, Brethauer SA, Andalib A, Punchai S, Mackey J, Rodriguez J, Rogula T, Kroh M, Schauer PR Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes [J]. Ann Surg, 2016, 264(4): 674, 681.
5.
Brethauer SA, Aminian A, Romero-Talamã s H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus [J]. Ann Surg, 2013, 258(4): 636–637.
6.
Buse JB, Caprio S, Cefalu WT, Ceriello A, del Prato S, Inzucchi SE, McLaughlin S, Phillips GL, Robertson RP, Rubino F, Kahn R, Kirkman MS How do we define cure of diabetes? [J]. Diabetes Care, 2009, 32(11): 2133–2135.
7.
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus [J]. Ann Surg, 2003, 238(4): 467–484.
8.
Rubino F, Kaplan LM, Schauer PR, et al. The diabetes surgery summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus [J]. Ann Surg. 2010;251(3):399–405.CrossRefPubMed
9.
Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes [J]. Arquivos Brasileiros De Endocrinologia E Metabologia. 2011;5(3):e171–89.
10.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes [J]. N Engl J Med. 2012;366(17):1567–76.CrossRefPubMedPubMedCentral
11.
Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012 Jan;99(1):100–3.CrossRefPubMed
12.
Digiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up [J]. Surg Obes Relat Dis. 2010;6(3):249–53.CrossRefPubMed
13.
Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass [J]. Surg Obes Relat Dis. 2010;6(3):254–9.CrossRefPubMed
14.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic [J]. Nature. 2001;414(6865):782–7.CrossRef
15.
Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes [J]. Ann Surg. 2010;252(6):966–71.CrossRefPubMed
16.
Rosenthal R, Li X, Samuel S, et al. Effect of sleeve gastrectomy on patients with diabetes mellitus [J]. Surg Obes Relat Dis. 2009;5(4):429–34.CrossRefPubMed
17.
Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity [J]. Obes Surg. 2010;20(9):1245–50.CrossRefPubMed
18.
Aarts EO. Janssen, et al. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery [J]. Obes Surg. 2013;23(7):867–73.CrossRefPubMed
19.
Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion [J]. Surgery. 2010;147(5):664–9.CrossRefPubMed
20.
Huang CK, Asim S, Chi-Hsien L, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25–35 [J]. Obes Surg. 2011;21(9):1344–9.CrossRefPubMedPubMedCentral
21.
Sjöström ML, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events [J]. Jama. 2012;307(1):56–65.CrossRefPubMed
22.
Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score [J]. Surg Obes Relat Dis. 2013;9(3):379–84.CrossRefPubMed
23.
National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998 Sep;6 Suppl 2:51S–209S
Metadata
Title
Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases
Authors
Wang Xiaosong
Su Chongyu
Shen Xuqi
Yu Peiwu
Zhao Yongliang
Publication date
01-04-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-03656-9

Other articles of this Issue 4/2019

Obesity Surgery 4/2019 Go to the issue

Original Contributions

Applying Enhanced Recovery After Bariatric Surgery (ERABS) Protocol for Morbidly Obese Patients With End-Stage Renal Failure

Video Submission

Laparoscopic Sleeve Gastrectomy After Orthotopic Liver Transplantation, Video Reported

Letter to the Editor

Outcome of Primary Obesity Surgery Endolumenal Procedure as Obesity Treatment in Private Practice Setting: an Intervention Study

Original Contributions

Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m2?: a Meta-analysis

Original Contributions

Virtual Reality Single-Port Sleeve Gastrectomy Training Decreases Physical and Mental Workload in Novice Surgeons: An Exploratory Study

Original Contributions

Association of Bariatric Surgery Status with Reduced HER2+ Breast Cancers: a Retrospective Cohort Study